ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 710342 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 710342; 2) Community: the network communities that were significantly associated with the response to NSC 710342; 3) Molecule: the relationships between components within communities and NSC 710342; 4) MDR: the compounds that were significantly associated with the NSC 710342.

NSC Compound Enrichment Correlation
NSC 682996 Null 0.0212053315848709 0.42588
NSC 685285 Null 0.0212053315848709 0.15747541
NSC 688228 Null 0.0212053315848709 0.13386293
NSC 711077 Null 0.0212053315848711 0.24783344
NSC 716503 Null 0.0212053315848711 0.12561624
NSC 718781 Erlotinib hydrochloride 0.0212053315848711 -0.20651667
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.0212053315848711 0.34326704
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0212053315848711 0.36048768
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.0212053315848711 0.37575508
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0212053315848711 0.37617233
Total:89  Current:44    [First] [Prev] [Next] [Last]